Laregab-NT LS Tablet is a combination medication containing Gabapentin 200 mg and Nortriptyline 10 mg, indicated for the management of neuropathic pain and certain chronic pain conditions. Gabapentin, an anticonvulsant, modulates calcium channels to reduce neuronal excitability, thereby alleviating neuropathic pain symptoms. Nortriptyline, a tricyclic antidepressant, enhances noradrenergic and serotonergic neurotransmission by inhibiting reuptake, contributing to analgesic effects and mood stabilization. The synergistic action of these agents provides improved pain control in patients with conditions such as diabetic neuropathy, postherpetic neuralgia, and fibromyalgia. Laregab-NT LS Tablet is typically administered orally, with dosage individualized based on clinical response and tolerability. Common adverse effects may include dizziness, somnolence, dry mouth, and gastrointestinal disturbances. Caution is advised in patients with a history of cardiac arrhythmias, glaucoma, or hepatic impairment. It is contraindicated in individuals with hypersensitivity to either component. Regular monitoring and dose adjustments are recommended to optimize therapeutic outcomes while minimizing side effects. Laregab-NT LS Tablet should be used under medical supervision, with consideration of potential drug interactions and contraindications to ensure safe and effective pain management.